Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.

Nichols AC, Lang P, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Fung K, de Almeida JR, Bayley A, Goldstein DP, Eskander A, Husain Z, Bahig H, Christopoulous A, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Mendez A, Winquist E, Read N, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Corsten M, Rajaraman M, Johnson-Obaseki S, Eapen L, Odell M, Chandarana S, Banerjee R, Dort J, Matthews TW, Hart R, Kerr P, Dowthwaite S, Gupta M, Zhang H, Wright J, Parker C, Wehrli B, Kwan K, Theurer J, Palma DA.

BMC Cancer. 2020 Feb 14;20(1):125. doi: 10.1186/s12885-020-6607-z.

2.

Surgical Site Infection Affects Length of Stay After Complex Head and Neck Procedures.

Lebo NL, Quimby AE, Caulley L, Thavorn K, Kekre N, Brode S, Johnson-Obaseki S.

Laryngoscope. 2020 Jan 24. doi: 10.1002/lary.28512. [Epub ahead of print]

PMID:
31977071
3.

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.

Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Eapen L, Odell M, Parker C, Wehrli B, Kwan K, Palma DA.

Lancet Oncol. 2019 Oct;20(10):1349-1359. doi: 10.1016/S1470-2045(19)30410-3. Epub 2019 Aug 12. Erratum in: Lancet Oncol. 2019 Dec;20(12):e663.

PMID:
31416685
4.

Comparing Hematoma Incidence between Hemostatic Devices in Total Thyroidectomy: A Systematic Review and Meta-analysis.

Hua N, Quimby AE, Johnson-Obaseki S.

Otolaryngol Head Neck Surg. 2019 Nov;161(5):770-778. doi: 10.1177/0194599819865248. Epub 2019 Jul 23.

PMID:
31331260
5.

An aggressive central giant cell granuloma in a pediatric patient: case report and review of literature.

Wang Y, Le A, El Demellawy D, Shago M, Odell M, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2019 Jul 18;48(1):32. doi: 10.1186/s40463-019-0356-5. Review.

6.

Influence of Socioeconomic Status on Stage at Presentation of Laryngeal Cancer in the United States.

Lebo NL, Khalil D, Balram A, Holland M, Corsten M, Ted McDonald J, Johnson-Obaseki S.

Otolaryngol Head Neck Surg. 2019 Nov;161(5):800-806. doi: 10.1177/0194599819856305. Epub 2019 Jun 11.

PMID:
31184265
7.

Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review.

Hersi M, Traversy G, Thombs BD, Beck A, Skidmore B, Groulx S, Lang E, Reynolds DL, Wilson B, Bernstein SL, Selby P, Johnson-Obaseki S, Manuel D, Pakhale S, Presseau J, Courage S, Hutton B, Shea BJ, Welch V, Morrow M, Little J, Stevens A.

Syst Rev. 2019 Jan 19;8(1):28. doi: 10.1186/s13643-018-0928-x.

8.

Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study.

Quimby AE, Lebo NL, Griffiths R, Hall S, Dimitroulakos J, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2018 Dec 4;47(1):74. doi: 10.1186/s40463-018-0322-7.

9.

C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer.

Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J.

Otolaryngol Head Neck Surg. 2019 Mar;160(3):494-501. doi: 10.1177/0194599818800297. Epub 2018 Sep 18.

PMID:
30226795
10.

Does Socioeconomic Status Affect Stage at Presentation for Larynx Cancer in Canada's Universal Health Care System?

Khalil D, Corsten MJ, Holland M, Balram A, McDonald JT, Johnson-Obaseki S.

Otolaryngol Head Neck Surg. 2019 Mar;160(3):488-493. doi: 10.1177/0194599818798626. Epub 2018 Sep 11.

PMID:
30200820
11.

Correction to: HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.

Wasserman JK, Rourke R, Purgina B, Caulley L, Dimitroulakos J, Corsten M, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2018 Aug 2;47(1):49. doi: 10.1186/s40463-018-0294-7.

12.

Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.

Lebo NL, Griffiths R, Hall S, Dimitroulakos J, Johnson-Obaseki S.

Head Neck. 2018 Aug;40(8):1697-1706. doi: 10.1002/hed.25152. Epub 2018 Jun 22.

PMID:
29934959
13.

Immediate versus delayed reconstruction of head and neck cutaneous melanoma.

Quimby AE, Khalil D, Johnson-Obaseki S.

Laryngoscope. 2018 Nov;128(11):2566-2572. doi: 10.1002/lary.27250. Epub 2018 Jun 22. Review.

PMID:
29932227
14.

Customized Viral Immunotherapy for HPV-Associated Cancer.

Atherton MJ, Stephenson KB, Pol J, Wang F, Lefebvre C, Stojdl DF, Nikota JK, Dvorkin-Gheva A, Nguyen A, Chen L, Johnson-Obaseki S, Villeneuve PJ, Diallo JS, Dimitroulakos J, Wan Y, Lichty BD.

Cancer Immunol Res. 2017 Oct;5(10):847-859. doi: 10.1158/2326-6066.CIR-17-0102. Epub 2017 Sep 14.

15.

Peri-operative factors predisposing to pharyngocutaneous fistula after total laryngectomy: analysis of a large multi-institutional patient cohort.

Lebo NL, Caulley L, Alsaffar H, Corsten MJ, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2017 Aug 23;46(1):54. doi: 10.1186/s40463-017-0233-z.

16.

Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature.

Quimby AE, Caulley L, Rodin D, Purgina B, Eapen L, Shier L, Johnson-Obaseki S.

J Med Case Rep. 2017 Mar 10;11(1):65. doi: 10.1186/s13256-017-1209-3. Review.

17.

Nasopharyngeal non-intestinal-type adenocarcinoma: a case report and updated review of the literature.

Jain C, Caulley L, Macdonald KI, Purgina B, Lai CK, Esche B, Johnson-Obaseki S.

Curr Oncol. 2017 Feb;24(1):e55-e60. doi: 10.3747/co.24.3299. Epub 2017 Feb 27.

18.

Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.

Rodin D, Caulley L, Burger E, Kim J, Johnson-Obaseki S, Palma D, Louie AV, Hansen A, O'Sullivan B.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):709-717. doi: 10.1016/j.ijrobp.2016.11.029. Epub 2016 Nov 27. Review.

PMID:
28244405
19.

Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program.

Caulley L, Johnson-Obaseki S, Luo L, Javidnia H.

Medicine (Baltimore). 2017 Feb;96(5):e5752. doi: 10.1097/MD.0000000000005752.

20.

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.

Wasserman JK, Rourke R, Purgina B, Caulley L, Dimitroulakos J, Corsten M, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2017 Jan 6;46(1):3. doi: 10.1186/s40463-016-0179-6. Erratum in: J Otolaryngol Head Neck Surg. 2018 Aug 2;47(1):49.

21.

Complication rates of open surgical versus percutaneous tracheostomy in critically ill patients.

Johnson-Obaseki S, Veljkovic A, Javidnia H.

Laryngoscope. 2016 Nov;126(11):2459-2467. doi: 10.1002/lary.26019. Epub 2016 Apr 14. Review.

PMID:
27075530
22.

Is there a group of patients at greater risk for hematoma following thyroidectomy? A systematic review and meta-analysis.

Quimby AE, Wells ST, Hearn M, Javidnia H, Johnson-Obaseki S.

Laryngoscope. 2017 Jun;127(6):1483-1490. doi: 10.1002/lary.26195. Epub 2016 Aug 2. Review.

PMID:
27481173
23.

Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.

Johnson-Obaseki SE, Labajian V, Corsten MJ, McDonald JT.

J Otolaryngol Head Neck Surg. 2015 Dec 2;44:53. doi: 10.1186/s40463-015-0107-1.

24.

Incidence of differentiated thyroid cancer in Canada by City of residence.

Corsten MJ, Hearn M, McDonald JT, Johnson-Obaseki S.

J Otolaryngol Head Neck Surg. 2015 Sep 15;44:36. doi: 10.1186/s40463-015-0088-0.

25.

Response to: "No evidence for improved TORS post-treatment feeding tube dependency rate relative to standard therapy in early stage oropharyngeal cancer".

Johnson-Obaseki S, Kelly K, Corsten M.

Oral Oncol. 2015 Sep;51(9):e68. doi: 10.1016/j.oraloncology.2015.06.001. Epub 2015 Jun 26. No abstract available.

PMID:
26120092
26.

Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors.

Dayekh K, Johnson-Obaseki S, Corsten M, Villeneuve PJ, Sekhon HS, Weberpals JI, Dimitroulakos J.

Mol Cancer Ther. 2014 Nov;13(11):2559-71. doi: 10.1158/1535-7163.MCT-13-1086. Epub 2014 Sep 4.

27.

Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review.

Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M.

Oral Oncol. 2014 Aug;50(8):696-703. doi: 10.1016/j.oraloncology.2014.04.005. Epub 2014 Jun 7. Review.

PMID:
24917389
28.

The relationship between survival and socio-economic status for head and neck cancer in Canada.

McDonald JT, Johnson-Obaseki S, Hwang E, Connell C, Corsten M.

J Otolaryngol Head Neck Surg. 2014 Jan 14;43:2. doi: 10.1186/1916-0216-43-2.

29.

Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007.

Hwang E, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M.

Oral Oncol. 2013 Nov;49(11):1072-6. doi: 10.1016/j.oraloncology.2013.08.002. Epub 2013 Sep 7.

PMID:
24018186
30.

Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006.

Guay B, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M.

Thyroid. 2014 Mar;24(3):552-5. doi: 10.1089/thy.2013.0308. Epub 2013 Nov 14.

PMID:
24003960
31.

Head and neck cancer in Canada: trends 1992 to 2007.

Johnson-Obaseki S, McDonald JT, Corsten M, Rourke R.

Otolaryngol Head Neck Surg. 2012 Jul;147(1):74-8. doi: 10.1177/0194599812437332. Epub 2012 Feb 10.

PMID:
22328702

Supplemental Content

Loading ...
Support Center